// App-Quantinova.ai

SAT0067 (2017) : FURTHER TREATMENT INTENSIFICATIONS IN UNDIFFERENTIATED AND RHEUMATOID ARTHRITIS PATIENTS ALREADY IN LOW DISEASE ACTIVITY HAVE LIMITED BENEFIT TOWARDS PHYSICAL FUNCTIONING

Researchers

Presenter

  • S.A. Bergstra

Principal Investigators

  • O. Olivas

  • G. Akdemir

  • N. Riyazi

  • G. Collee

  • J.H. Van Groenendael

  • R.B. Landew

  • C.F. Allaart

Medical Centers

  • Pathology, LUMC, Leiden, Netherlands

  • Histopathology, Hospital Universitario 12 de Octubre, Madrid, Spain

  • Medical Center Haaglanden, The Hague

  • Reumazorg Southwest Netherlands, Bergen op Zoom

  • Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands

  • Zuyderland Medical Center, Heerlen, Netherlands

Locations

  • Netherlands

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • sulphasalazine

  • Methotrexate

  • Adalimumab

  • Prednisone

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved